Y-Intercept (HK)’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-186,544
Closed -$91.4K 1776
2023
Q2
$91.4K Buy
+186,544
New +$153K 0.01% 1119
2021
Q2
Sell
-6,453
Closed -$286K 965
2021
Q1
$286K Buy
+6,453
New +$440K 0.08% 422

Other funds holding CELL

Y-Intercept (HK)'s CELL Position: Q3 2023 in Review

Y-Intercept (HK) sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 186,544 shares — an estimated $91.4K sold.

Y-Intercept (HK) first reported a position in CELL in Q1 2021 and held it in 2 quarters. The position peaked at $286K in Q1 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Y-Intercept (HK) reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Y-Intercept (HK) sold 186,544 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $91.4K.
  • Y-Intercept (HK) first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Y-Intercept (HK)'s PhenomeX Inc. Common Stock position peaked at $286K in Q1 2021.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Y-Intercept (HK)'s 13F filing for Q3 2023, filed 14 Nov 2023.